Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate a Remote, Decentralized, Direct-to-Patient Strategy for Clinical Research Engagement of Patients With Small Cell Lung Cancer (SCLC).

NCT06486428 is registered in ClinicalTrials.gov with Addario Lung Cancer Medical Institute as lead sponsor.

NCT NCT06486428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06486428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate a Remote, Decentralized, Direct-to-Patient Strategy for Clinical Research Engagement of Patients With Small Cell Lung Cancer (SCLC).
Lead sponsor
Addario Lung Cancer Medical Institute
Phase
Observational
Overall status
Active, not recruiting
Start date
May 23, 2025
Completion date
December 31, 2026
Enrollment
22 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

small-cell lung cancer